ABBO News

US Markets
US Economy
Business
Finance
Technology
Press Release
Subscribe Now For Free

US Markets
US Economy
Business
Finance
Technology
Press Release
Subscribe Now For Free

US Markets
US Economy
Business
Finance
Technology
Press Release
Subscribe Now For Free

NASDAQ: ITCI

Healthcare

Johnson & Johnson Beats Q4 Sales and Profit Estimates on Cancer Drug Sales

Maria Reed / 22 January 2025

Johnson & Johnson (NYSE: JNJ), fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular (NASDAQ: ITCI), reported fourth-quarter […]

Johnson & Johnson Beats Q4 Sales and Profit Estimates on Cancer Drug Sales Read More »

Healthcare

Johnson & Johnson to Buy Neurological Drug Maker Intra-Cellular for $14.6 Billion

Jennifer Tacker / 13 January 2025

On Monday, Johnson & Johnson (NYSE: JNJ) said it would buy neurological drug maker Intra-Cellular Therapies (NASDAQ: ITCI) for $14.6

Johnson & Johnson to Buy Neurological Drug Maker Intra-Cellular for $14.6 Billion Read More »

Company

Legal

Editorial Policy

Disclaimer

Modern Slavery Statement

Anti Bribery And Corruption Policy

Top Tech Stocks 2025

Top Bank Stocks 2025

Worst Stocks 2025

We Are Licensed Partners Of Reuters